Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | DNM2 | P50570 | 9/20 | 0.43 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17564584 | 0.90 | KMT2A (0.49) | KMT2AMAPTHTTNPSR1DNM2 | |
| SCHEMBL9789568 | 0.84 | KMT2A (0.54) | KMT2AMAPTHTTNPSR1NR1I2 | |
| SCHEMBL9789554 | 0.84 | KMT2A (0.54) | KMT2AMAPTHTTNPSR1NR1I2 | |
| SCHEMBL11787843 | 0.82 | KMT2A (0.83) | KMT2AMAPTHTTNPSR1DNM2 | |
| SCHEMBL11652521 | 0.82 | NR5A1 (0.40) | KMT2AMAPTLMNAALDH1A1 | |
| SCHEMBL7937257 | 0.82 | KMT2A (0.77) | KMT2ADNM2KCNH3NR1I2AHR | |
| SCHEMBL1562316 | 0.82 | KMT2A (0.77) | KMT2ADNM2KCNH3NR1I2AHR | |
| SCHEMBL17563553 | 0.82 | KMT2A (0.77) | KMT2ADNM2KCNH3NR1I2AHR | |
| SCHEMBL11395631 | 0.82 | NR5A1 (0.40) | KMT2AMAPTLMNAALDH1A1 | |
| SCHEMBL17563551 | 0.82 | NR5A1 (0.40) | KMT2AMAPTLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299504-B2 | Process for preparing a triazine-based precursor, the precursor prepared thereby, a method for producing a micro-particulate complex using the precursor, and the micro-particulate complex produced thereby | NATIONAL CHI NAN UNIVERSITY (TW) | 2022-04-12 | — | — | US | disclosed |
| CN-109400543-B | Triazine precursor, method for preparing triazine precursor and application of triazine precursor | 暨南国际大学 | 2022-03-01 | — | — | CN | disclosed |
| US-20200369687-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | NATIONAL CHI NAN UNIVERSITY (TW) | 2020-11-26 | — | — | US | disclosed |
| US-20190055270-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | NATIONAL CHI NAN UNIVERSITY (TW) | 2019-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055270-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | SSRP1, RRP15, SUB1 | KMT2A 2946/4885MAPT 1446/4885HTT 1166/4885 |
| US-11299504-B2 | Process for preparing a triazine-based precursor, the precursor prepared thereby, a method for producing a micro-particulate complex using the precursor, and the micro-particulate complex produced thereby | SSRP1, RRP15, SUB1 | KMT2A 2946/4885MAPT 1446/4885HTT 1166/4885 |
| US-20200369687-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | SSRP1, RRP15, SUB1 | KMT2A 2946/4885MAPT 1446/4885HTT 1166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.